Selected oncological patients may even restart cancer treatment after in-hospital cardiac arrest
To the Editor,
We read with great interest the article by Guha and colleagues in a recent issue of Resuscitation. 1 The authors retrospectively reviewed more than 110,000 admissions of oncological patients that were complicated by in-hospital cardiac arrest (IHCA) between 2003À2014. The proportion of oncological patients who survived hospitalization varied from 23 % to 30 %, similar to a previous study, 2 despite lower rates of post-IHCA procedural utilization in oncological patients compared to patients without cancer. The authors concluded that application of potentially life-saving interventions could improve survival in cancer patients after an IHCA. Additionally, a multicenter study in France evaluating 133 cancer patients showed that 18 % survived after an IHCA, with an overall six-month survival of 14 %, leading the authors to indicate intensive care unit (ICU) admission and initial full-code management for selected patients. 3 To contribute with such statements, we analyzed oncological patients admitted to ICU after an IHCA in a cancer center. Between January 2010 and December 2017, 25,983 adult patients were admitted to the ICUs of AC Camargo Cancer Center (São Paulo, Brazil), among them 112 (0.4 %) were admitted after an IHCA with return of spontaneous circulation. The ICU and in-hospital survival were 27 % and 21 %, respectively. At ICU admission and adjusting for age and sex, hospital survivors had less metastatic solid tumors, more controlled cancer, lower acute physiological status (lower SAPS 3 score) and lower infection rate. Additionally, patients discharged from hospital came more frequently from monitored hospital units and achieved return of spontaneous circulation sooner than patients that died during the hospital stay (Table 1) . From ICU admission, the overall six-month survival was 11.6 %, while among patients discharged from hospital (n = 24), the median survival time was 208 days and the six-month survival was 54.2 %. Unlike Guha and colleagues, we analyzed patients with metastasis and observed encouraging findings: although their hospital survival was lower than the survival of patients without metastasis (13 % vs 36 %, p < 0.01), it was almost twice as high as the previously reported of 7.8 % for patients with metastatic cancer. 4 Thirteen patients (54.2 %) restarted cancer treatment (chemotherapy, radiotherapy or surgery), five during the hospital stay and eight after the hospital discharge. After the ICU admission, the median days to restart cancer treatment was 16 days (minimum 5 days and maximum 48 days). Adjusted for age and sex, the only variable associated with recommencement of cancer treatment was a lower SAPS3 score at ICU admission [OR = 0.94 (95 %CI = 0.91À0.97)], coincidently the same OR observed for the association of SAPS3 and hospital survival.
Combining the above-mentioned studies with the recent advances in short-term outcomes of critically ill cancer patients, 5 we believe that IHCA should not be perceived as a dismal event to all cancer patients. We expect further large multicenter research on 
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